Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for MedRx Co. Ltd. (4586:JPX), powered by AI.
MedRx Co. Ltd. is currently trading at ¥54. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for MedRx Co. Ltd. on Alpha Lenz.
View MedRx Co. Ltd.'s valuation metrics on Alpha Lenz.
“MedRx Co. Ltd.'s ROE is -44.4%. Explore profitability and growth together.”
Ask for details →MedRx Co. Ltd. is a pharmaceutical company engaged in the development, production, and marketing of innovative medical products. Specializing in drug delivery systems, MedRx Co. Ltd. focuses on transdermal and intradermal methods, enhancing how therapeutics are administered to patients. The company is well-regarded for its commitment to improving drug efficacy and patient experience through pioneering technologies and formulations. By collaborating with healthcare sectors, research institutions, and biotech industries, MedRx Co. Ltd. plays a crucial role in extending the therapeutic options available to providers and their patients. Based in Japan and operating on an international scale, the company continues to make a significant impact on the pharmaceutical and healthcare markets, contributing to advancements in patient care and treatment methodologies.
“MedRx Co. Ltd.'s ROE is -44.4%. Explore profitability and growth together.”
Ask for details →MedRx Co. Ltd. (ticker: 4586) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 22 employees.
The current price is 54 with a P/E ratio of -x and P/B of -x.
ROE is -44.44% and operating margin is -735.45%. Annual revenue is $128M.